COMMUNIQUÉS West-GlobeNewswire

MEDIA ADVISORY - Protests Against Ford Government’s Expanding Hospital Privatization Plans
22/09/2025
TORONTO, Sept. 22, 2025 (GLOBE NEWSWIRE) -- “The Ford government is privatizing our public hospitals in a move that is costing patients thousands of dollars and taking away from our local public hospital services. [...]
The Sentinel Introduces Transformative Approach to Healing in British Columbia, Setting a New Standard in Integrative Care
22/09/2025
KASLO, BC, Sept. 22, 2025 (GLOBE NEWSWIRE) -- The Sentinel , a leading wellness centre, today announced a major initiative advancing the integration of traditional healing practices with contemporary therapeutic [...]
Semnur Pharmaceuticals, Inc. (“Semnur”), a Majority-Owned Subsidiary of Scilex Holding Company (Nasdaq: SCLX, “Scilex”), and Denali Capital Acquisition Corp. Announce the Closing of Their Previously Announced Business Combination
22/09/2025
Semnur’s shares of common stock and warrants are expected to continue to trade on the OTC Markets under the ticker symbols “SMNR” and “SMNRW”, respectively. Scilex (together with its affiliates) owns approximately 87.5 [...]
Lexicon Pharmaceuticals Announces Update on Submission of Additional Data to U.S. FDA Supporting the Benefit-Risk Profile of Zynquista® in Type 1 Diabetes
22/09/2025
Data obtained from ongoing third-party funded, investigator-sponsored trials have been submitted in effort to address the December 2024 complete response letter Company seeks alignment on reasonable path forward for [...]
Until Labs Announces $58M Series A Funding Round, to Develop an Organ Cryopreservation Product for Transplant Patients and Surgeons
22/09/2025
This investment, led by Founders Fund with participation from Lux Capital and Field Ventures, brings total investment to date to $100M+, and will be used to build out the team and operational infrastructure SAN [...]
Eupraxia Pharmaceuticals Announces Proposed Public Offering of Common Shares
22/09/2025
VICTORIA, British Columbia, Sept. 22, 2025 (GLOBE NEWSWIRE) -- Eupraxia Pharmaceuticals Inc. (“Eupraxia” or the “Company”) (NASDAQ:EPRX) (TSX:EPRX), a clinical-stage biotechnology company leveraging its proprietary [...]
InBrain Pharma to Present Long-Term Follow-Up Clinical Data from Its Phase I/II DIVE-I Trial in Parkinson’s Disease at the MDS 2025 Conference
22/09/2025
InBrain Pharma to Present Long-Term Follow-Up Clinical Data from Its Phase I/II DIVE-I Trial in Parkinson’s Disease at the MDS 2025 Conference Lille, September 22, 2025 – InBrain Pharma, a company specialized in the [...]
Angelini Pharma Signs Exclusive Option Agreement With Sovargen To License Global Development and Commercialization Rights For Innovative Brain Health Asset
22/09/2025
Angelini Pharma secures exclusive option to license global development and commercialization rights for SVG105 1 , a pre-clinical investigational novel compound with broad potential to treat brain health diseases, [...]
Humanitarian Nonprofit Human Appeal Canada to Host Second Annual Comedy Tour
22/09/2025
Joy and Impact Unleashed as Comedy Tour Funds Critical Relief for Those in Need TORONTO, Sept. 22, 2025 (GLOBE NEWSWIRE) -- Humanitarian aid nonprofit, Human Appeal Canada , is kicking off their second annual comedy [...]
Guerbet : Evolution de la Direction Générale
22/09/2025
Evolution de la Direction Générale Villepinte, le 22 septembre 2025, 17h45 : Guerbet (FR0000032526 GBT), spécialiste mondial des produits de contraste et solutions pour l’imagerie médicale, annonce la nomination de [...]
Guerbet : Change in General Management
22/09/2025
Change in General Management Villepinte France, September 22nd, 2025 : Guerbet (FR0000032526 GBT), a global specialist in contrast agents and solutions for medical imaging, announces the appointment of Mr. Jérôme [...]
New mobile units to drive early breast cancer detection in Alberta
22/09/2025
Alberta Cancer Foundation and Primary Care Alberta bring life-saving breast cancer screening to women in rural and remote communities EDMONTON, Alberta, Sept. 22, 2025 (GLOBE NEWSWIRE) -- Breast cancer screening is now [...]
IBA SA – NOTIFICATION TRANSPARENCE
22/09/2025
(Article 14, alinéa 1 er de la loi du 2 mai 2007 relative à la publicité des participations importantes) Louvain-la-Neuve (Belgique), le 22 septembre 2025, 18h00 Résumé de la notification IBA (Ion Beam Applications S.A [...]
IBA – Transparency Notification
22/09/2025
(Article 14, paragraph 1 of the law of 2 May 2007 on the disclosure of major holdings) Louvain-la-Neuve (Belgium), 22 September 2025, 06:00 PM Summary of the notification IBA (Ion Beam Applications S.A - EURONEXT - [...]
Fairhaven Health Develops Clinical Nutrition-Based Formulas to Support Women with PCOS and PMS
22/09/2025
MIDDLETOWN, Conn., Sept. 22, 2025 (GLOBE NEWSWIRE) -- During September’s PCOS Awareness Month, Fairhaven Health is drawing attention to the role targeted nutrition can play in supporting women affected by polycystic [...]
API Launches the Life Sciences Placement Program in Partnership with Mitacs at the Life Sciences Week Kick-Offs
22/09/2025
EDMONTON, Alberta and CALGARY, Alberta, Sept. 22, 2025 (GLOBE NEWSWIRE) -- This morning, at events in Edmonton and Calgary, Applied Pharmaceutical Innovation (API) proudly announced the launch of its new Life Sciences [...]
Synergy CHC (NASDAQ: SNYR) Taps Former Coca-Cola Executive to Lead Strategic Partnerships; Appoints Veteran Costco Buyer to Board of Directors
22/09/2025
Board member Scott Woodburn transitions to Head of Strategic Partnerships to accelerate FOCUSfactor Energy Drink expansion Former Costco Buyer Teresa Thompson brings nearly 40 years of retail expertise in vitamins and [...]
Immutep Announces Research Collaboration with the George Washington University Cancer Center to Evaluate Neoadjuvant Efti
22/09/2025
GW Cancer Center to initiate Phase II trial evaluating neoadjuvant efti as monotherapy and in combination with chemotherapy prior to surgery in HR+/HER2-neg breast cancer patients Second investigator-initiated trial to [...]
MediciNova Announces Completion of Patient Enrollment in COMBAT-ALS Phase 2b/3 Clinical Trial of MN-166 (ibudilast)
22/09/2025
~Patient Recruitment Closed~ LA JOLLA, Calif., Sept. 22, 2025 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ:MNOV) and the Standard Market of the Tokyo Stock [...]

Pages